Updated Outcomes of Gefitinib Alone vs Gefitinib Plus Chemotherapy in Patients With EGFR-Mutated NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated EGFR
J. Clin. Oncol 2022 Aug 12;[EPub Ahead of Print], E Miyauchi, S Morita, A Nakamura, Y Hosomi, K Watanabe, S Ikeda, M Seike, Y Fujita, K Minato, R Ko, T Harada, K Hagiwara, K Kobayashi, T Nukiwa, A InoueFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.